Compare Enzyme (MLN) vs ssv.network (SSV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs ssv.network — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while ssv.network trades at Rp36,581 (market cap Rp581,53M, Rp85,17M 24h volume). The key difference: ssv.network is far larger — about 4.3× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 15,8M SSV for ssv.network. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and ssv.network for 31 Days on average.
| MLN | SSV | |
|---|---|---|
Market Cap | Rp134,13M | Rp581,53M |
Volume (24h) | Rp104,56M | Rp85,17M |
Circulating Supply | 3,3M MLN | 15,8M SSV |
Typical Hold Time | 29 Days | 31 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
SSV is currently trading at Rp36,493 with a market cap of Rp581.32M, showing bearish technical signals across moving averages but neutral oscillators. The token is trading near key support at Rp35,859 with RSI_6 at 20.49 suggesting potential oversold conditions. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunity lies in potential oversold bounce from support levels, while major risks include continued downward pressure and limited fundamental catalysts. Investors should monitor volume patterns and network activity for directional cues.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About ssv.network
ssv.network is the first public implementation of the SSV primitive, which originated as a research piece by the Ethereum Foundation back in 2019 and since then has grown to a DAO governed, community driven network of stakers, builders and node operators. It functions as a distributed validator technology (DVT) project for Ethereum validators under development by Blox with grant funding distributed to supporting teams from the SSV DAO Treasury.
Read more on SSV →
